Lexicon Pharmaceuticals Inc Revenue per Employee (LXRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lexicon Pharmaceuticals Inc   (NASDAQ: LXRX)
 

Lexicon Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Lexicon Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 511,963, below the company average number of $774,858.
Within the Healthcare sector Employees of 95 other companies have achieved higher revenue per employee. While Lexicon Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 904 to 1008. Lexicon Pharmaceuticals Inc has 81 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LXRX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -97.6 % 1572.11 % -79.31 % 710.4 % 1652.64 %
Sales per Employee (TTM) $ 511,963 859,790 614,852 874,864 721,383
LXRX's Total Ranking # 1008 # 904 # 2001 # 1991 #
Seq. Revenue Change -96.72 % 284.16 % -61.27 % -50.87 % 2187.32 %

LXRX Company Profile >> Back to LXRX Efficiency Comparisons >> Compare LXRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 69
Healthcare Sector # 96
Overall Market # 1008

Revenue per Employee Statistics
High Average Low
$ 4,079,222 $ 774,858 $ 1,556
(Sep 30 2019)   (Mar 31 2023)



Financial Statements
Lexicon Pharmaceuticals Inc 's Revenue MRQ $ 1 Millions Visit LXRX's Income Statement
Lexicon Pharmaceuticals Inc 's Revenues TTM $ 41 Millions Visit LXRX's aggregate revenue growth
What are LXRX's Sales? Visit LXRX's Sales by Segment




Other Ratios
Lexicon Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LXRX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LXRX's Competitors
Revenue per Employee for LXRX's Suppliers
Revenue per Employee for LXRX's Customers

You may also want to know
LXRX's Sales Growth Rates LXRX's Pe Price to earnings ratio LXRX's Receivables Turnover Ratio LXRX's Stock Quote
LXRX's Net Income Growth Rates LXRX's Ps Price to Sales ratio LXRX's Sales per Employee LXRX's Asset Turnover Ratio
LXRX's Net Margin LXRX's Pb Price to Book ratio LXRX's Financial Strength Ratios LXRX's Dividend Payout Ratio
Date modified: 2026-09-08T13:54:57+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Verastem Inc   858,098.04 $ 87.526  Million 102 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Vir Biotechnology Inc   826,231.61 $ 303.227  Million 367 
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Prothena Corporation Public Limited Company  813,880.60 $ 54.530  Million 67 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 
Adma Biologics Inc   789,697.06 $ 510.934  Million 647 
Septerna Inc   760,630.77 $ 98.882  Million 130 
Dyadic International Inc   760,447.40 $ 3.802  Million 5 
Transmedics Group Inc   744,396.44 $ 668.468  Million 898 
Aveanna Healthcare Holdings Inc   743,662.86 $ 2,602.820  Million 3,500 
Veracyte Inc   721,503.31 $ 544.735  Million 755 
Xtant Medical Holdings Inc   720,185.43 $ 108.748  Million 151 
Harrow Inc   719,172.77 $ 274.724  Million 382 
Ars Pharmaceuticals Inc   717,343.56 $ 116.927  Million 163 
Sunshine Biopharma Inc   706,935.44 $ 35.347  Million 50 
Johnson and Johnson  695,518.47 $ 97,929.000  Million 140,800 
Mannkind Corporation  664,915.54 $ 393.630  Million 592 
Intuitive Surgical Inc   663,668.41 $ 11,296.300  Million 17,021 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.